Cipla USA, Inc. 2026-07-08 Health serious FDA
Health · FDA · Recall #FDA-D-0661-2026
Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactured by: Cipla… Recall
Issued July 8, 2026 · Cipla USA, Inc.
In July 2026, Cipla USA, Inc. recalled the Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactured by: Cipla…, a serious health recall reported by the FDA.
Compiled by Dana Whitfield, RecallCheckr
What this means for you
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
What you should do
- 1 Stop using Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactured by: Cipla… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Cipla USA, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Cipla USA, Inc.
- Category
- Health
- Recall date
- July 8, 2026
- Units affected
- Not reported
- Sold at
- USA Nationwide
- Recall number
- FDA-D-0661-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Cipla USA, Inc. has 10 recalls in our database.
- We're tracking 3,673 Health recalls in our database.
- This is the 453rd Health recall we've logged in 2026.